Blocking enzyme could hold the key to treating severe COVID-19

Blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms.

Related Keywords

Ohio ,United States ,Columbus ,Egypt ,Ohio State University ,American ,Jeffrey Kawahara ,Jacob Yount ,Eugene Oltz ,Parker Denz ,Ashley Zani ,Xiaoli Zhang ,Amy Webb ,Emily Hemann ,Cierra Carafice ,Asmaa Badr ,Mostafa Eltobgy ,Eunsoo Kim ,Estelle Cormet Boyaka ,Adrian Eddy ,Jianrong Li ,Adam Kenney ,Mijia Lu ,Andrea Tedeschi ,Maciej Pietrzak ,Oscar Rosas Gavrilin ,Jian Zhu ,Shahid Nimjee ,Richard Robinson ,Emily Caldwell ,Mark Peeples ,Kamal Amer ,Owen Whitham ,Emory University ,Ohio State Distinguished University Fellowship ,National Institutes Of Health ,Cystic Fibrosis Foundation ,Columbia University ,Nile University ,Ohio State Department Of Microbial Infection ,Proceedings Of The National Academy Sciences ,American Lung Association ,Ohio State University College Of Medicine ,Ohio State University College ,National Academy ,Ohio State ,National Institutes ,Microbial Infection ,Ohio State Distinguished University ,Shady Estfanous ,Kylene Daily ,Prosper Boyaka ,Abigail Wexner Research Institute ,Nationwide Children ,